Ligand Pharmaceuticals
LGND
LGND
256 hedge funds and large institutions have $2.61B invested in Ligand Pharmaceuticals in 2017 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 111 increasing their positions, 95 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
256
Holders Change
-13
Holders Change %
-4.83%
% of All Funds
6.38%
Holding in Top 10
5
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-37.5%
% of All Funds
0.12%
New
26
Increased
111
Reduced
95
Closed
30
Calls
$11.9M
Puts
$36.3M
Net Calls
-$24.4M
Net Calls Change
-$8.3M
Top Buyers
1 |
BlackRock
New York
|
+$277M |
2 |
SCM
Scopia Capital Management
New York
|
+$68.1M |
3 |
William Blair Investment Management
Chicago,
Illinois
|
+$54.4M |
4 |
EVM
Eaton Vance Management
Boston,
Massachusetts
|
+$11.3M |
5 |
Renaissance Technologies
New York
|
+$10.7M |